Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 2/2017

01-02-2017 | Urology – Letter to the Editor

Responses: Re: Csaba Berczi, Ben Thomas, Zsolt Bacso, Tibor Flasko. Bilateral renal cancers: oncological and functional outcomes. Int Urol Nephrol 2016 (Epub ahead of print)

Author: Csaba Berczi

Published in: International Urology and Nephrology | Issue 2/2017

Login to get access

Excerpt

Editor, …
Literature
1.
Chan AA, Wood CG, Caicedo J, Munsell MF, Matin SF (2010) Predictors of unilateral renal function after open and laparoscopic partial nephrectomy. Urology 75:295–302CrossRefPubMed
2.
Ching CB, Lane BR, Campbell SC, Li J, Fergany AF (2013) Five to 10-year follow-up of open partial nephrectomy in a solitary kidney. J Urol 190:470–474CrossRefPubMed
3.
Mir MC, Campbell RA, Sharma N et al (2013) Parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis. Urology 82:263–268CrossRefPubMed
4.
Patel AR, Eggener SE (2011) Warm ischemia less than 30 minutes is not necessarily safe during partial nephrectomy: every minute matters. Urol Oncol 29:826–828CrossRefPubMed
5.
La Rochelle J, Shuch B, Riggs S et al (2009) Functional and oncological outcomes of partial nephrectomy of solitary kidneys. J Urol 181:2037–2042CrossRefPubMed
6.
Shekarriz B, Shah G, Upadhyay J (2004) Impact of temporary hilar clamping during laparoscopic partial nephrectomy on postoperative renal function: a prospective study. J Urol 2:54–57CrossRef
7.
Thompson RH, Lane BR, Lohse CM et al (2012) Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 79:356–360CrossRefPubMed
8.
Mason RJ, Abdolell M, Trottier G et al (2011) Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. Eur Urol 59:863–867CrossRefPubMed
9.
Nguyen MM, Gill IS (2009) Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol 181:1020–1027CrossRefPubMed
10.
Volpe A, Cadeddu JA, Cestari A et al (2011) Contemporary management of small renal masses. Eur Urol 60:501–515CrossRefPubMed
Metadata
Title
Responses: Re: Csaba Berczi, Ben Thomas, Zsolt Bacso, Tibor Flasko. Bilateral renal cancers: oncological and functional outcomes. Int Urol Nephrol 2016 (Epub ahead of print)
Author
Csaba Berczi
Publication date
01-02-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1500-z

Other articles of this Issue 2/2017

International Urology and Nephrology 2/2017 Go to the issue

Urology - Original Paper

Split renal function of both kidneys after robot-assisted partial nephrectomy for renal tumor larger than 4 cm

Nephrology - Original Paper

Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients

Erratum

Erratum to: Urinary angiotensin converting enzyme 2 is strongly related to urinary nephrin in type 2 diabetes patients

Urology - Original Paper

Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion

Nephrology - Original Paper

Hypoalbuminemia: a risk factor for acute kidney injury development and progression to chronic kidney disease in critically ill patients

Nephrology - Original Paper

Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits